Yes 010 (Hip study) will also add further proof...there is anecdotal evidence so far in SAS for more than one joint simultaneously...but Hip study will get it onto label and give Medical Associations and Docs assurity of being able to prescribe off label.
PAR Capital Position and 2024 Raising Requirements, page-59
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.95M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.5¢ | 22.0¢ | $65.40K | 290.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 96390 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 138166 | 5 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |